Patient perspectives on telemedicine use in rheumatology during the COVID-19 pandemic: survey results from the COVID-19 Global Rheumatology Alliance.

COVID-19 Qualitative Rheumatic disease Survey Telemedicine

Journal

Clinical rheumatology
ISSN: 1434-9949
Titre abrégé: Clin Rheumatol
Pays: Germany
ID NLM: 8211469

Informations de publication

Date de publication:
08 Aug 2023
Historique:
received: 06 04 2023
accepted: 22 07 2023
revised: 15 06 2023
medline: 8 8 2023
pubmed: 8 8 2023
entrez: 8 8 2023
Statut: aheadofprint

Résumé

The COVID-19 pandemic resulted in rapid adoption of telemedicine in rheumatology. We described perspectives of patients with rheumatic diseases related to telemedicine use. An anonymous online survey for people with rheumatic diseases was launched in January 2021. We collected data on reasons for telemedicine use, perceived benefits, disadvantages and obstacles of telemedicine, perceived telemedicine effectiveness for different clinical tasks, level of satisfaction with telemedicine use, and future preferences for telemedicine. We summarized results with descriptive statistics and identified themes in free text responses to describe perspectives of telemedicine qualitatively. We received 596 complete responses (85% female and 47% 41-60 years old). During the COVID-19 pandemic, 78% (467/596) of respondents used telemedicine, and 61% (283/467) of telemedicine users reported that telemedicine was as effective or more effective than an in-person visit. Younger participants and those in North America reported effectiveness and satisfaction with telemedicine at higher frequencies. Participants reported similar effectiveness to in-person visits for making medication changes and discussing disease symptoms or complications. Most respondents found telemedicine at least as effective as in-person visits. Participants found telemedicine to be effective for specific scenarios, such as making medication changes and discussion of disease activity. Telemedicine may continue to be of importance in the care of patients with rheumatic diseases post pandemic, but likely for specific subsets of patients for specific visit indications. Key Points • Most patients with rheumatic disease found telemedicine as effective as in-person visits, particularly for some indications.

Identifiants

pubmed: 37552351
doi: 10.1007/s10067-023-06717-2
pii: 10.1007/s10067-023-06717-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).

Références

Gkrouzman E, Wu DD, Jethwa H, Abraham S (2020) Telemedicine in rheumatology at the advent of the COVID-19 pandemic. HSS J 16(Suppl 1):1–4
Santos-Moreno P, Chavez-Chavez J, Hernández-Zambrano SM, Rivera-Triana DP, Castiblanco-Montañez RA, Aza A, Buitrago-Garcia D, Villarreal L, Rojas-Villarraga A (2020) Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic. Ann Rheum Dis 80(5):e65–e65
doi: 10.1136/annrheumdis-2020-218165 pubmed: 32586920
Ziadé N, Hmamouchi I, El Kibbi L, Abdulateef N, Halabi H, Abutiban F, Hamdi W, El Rakawi M, Eissa M, Masri B (2020) The impact of COVID-19 pandemic on rheumatology practice: a cross-sectional multinational study. Clin Rheumatol 39(11):3205–3213
doi: 10.1007/s10067-020-05428-2 pubmed: 32996071 pmcid: 7524572
Shenoy P, Ahmed S, Paul A, Skaria TG, Joby J, Alias B (2020) Switching to teleconsultation for rheumatology in the wake of the COVID-19 pandemic: feasibility and patient response in India. Clin Rheumatol 39(9):2757–2762
doi: 10.1007/s10067-020-05200-6 pubmed: 32474883 pmcid: 7260460
Maheswaranathan M, Chu P, Johannemann A, Criscione-Schreiber L, Clowse M, Leverenz DL (2022) The impact of the COVID-19 pandemic and telemedicine implementation on practice patterns and electronic health record utilization in an academic rheumatology practice. J Clin Rheumatol 28(2):e612–e615
doi: 10.1097/RHU.0000000000001751 pubmed: 33843775
Cavagna L, Zanframundo G, Codullo V, Pisu MG, Caporali R, Montecucco C (2021) Telemedicine in rheumatology: a reliable approach beyond the pandemic. Rheumatology (Oxford) 60(1):366–370
doi: 10.1093/rheumatology/keaa554 pubmed: 32893293
Opinc A, Łukasik Z, Makowska J (2020) The attitude of Polish rheumatology patients towards telemedicine in the age of the COVID-19 pandemic. Reumatologia 58(3):134–141
doi: 10.5114/reum.2020.96665 pubmed: 32684645 pmcid: 7362273
Oh Y, Hennessey A, Young L, Barrett C (2022) Evaluation of patient satisfaction for telehealth (telephone and video) in rheumatology outpatients during COVID-19 pandemic. Intern Med J 52(4):559–565
doi: 10.1111/imj.15663 pubmed: 34897948
López-Medina C, Escudero A, Collantes-Estevez E (2020) COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases. Ann Rheum Dis 80(4):e50–e50
doi: 10.1136/annrheumdis-2020-218008 pubmed: 32503860
Hsieh HF, Shannon SE (2005) Three approaches to qualitative content analysis. Qual Health Res 15(9):1277–1288
doi: 10.1177/1049732305276687 pubmed: 16204405
Sloan M, Lever E, Harwood R, Gordon C, Wincup C, Blane M, Brimicombe J, Lanyon P, Howard P, Sutton S et al (2022) Telemedicine in rheumatology: a mixed methods study exploring acceptability, preferences and experiences among patients and clinicians. Rheumatology (Oxford) 61(6):2262–2274
doi: 10.1093/rheumatology/keab796 pubmed: 34698822
Danila MI, Gavigan K, Rivera E, Nowell WB, George MD, Curtis JR, Christopher-Stein L, Banerjee S, Merkel PA, Young K et al (2022) Patient perceptions and preferences regarding telemedicine for autoimmune rheumatic diseases care during the COVID-19 pandemic. Arthritis Care Res (Hoboken) 74(7):1049–1057
doi: 10.1002/acr.24860 pubmed: 35040274
Mortezavi M, Lokineni S, Garg M, Chen YL, Ramsey A (2021) Rheumatology patient satisfaction with telemedicine during the COVID-19 pandemic in the United States. J Patient Exp 8:23743735211008824
pubmed: 34179440 pmcid: 8205414
Chock EY, Putman M, Conway R, Danila MI, Hoyer B, Hsieh E, Jayatilleke A, Kilian A, Leipe J, Liew JW et al (2022) Experience with telemedicine among rheumatology clinicians during the COVID-19 pandemic: an international survey. Rheumatol Adv Pract 6(2):rkac039
doi: 10.1093/rap/rkac039 pubmed: 35669677 pmcid: 9154733
Benson C VM, Schieir O, Vitone G, Tirpack A, Jones M, Bessette L, Boire G, Hazlewood G, Hitchon C, Keystone E, Pope J, Thorne C, Bartlett S, Bingham III C, Bykerk V, (CATCH) Investigators C (2020) Can a clinical disease activity index based on patient-reported joint counts (PT-CDAI) be used to inform target-based care in telemedicine? An analysis of 2 early RA cohort studies [abstract]. Arthritis Rheumatol. 72 (suppl 10). https://acrabstracts.org/abstract/can-a-clinical-disease-activity-index-based-on-patient-reported-joint-counts-pt-cdai-be-used-to-inform-target-based-care-in-telemedicine-an-analysis-of-2-early-ra-cohort-studies/ . Accessed May 25, 2023.
Bos WH, van Tubergen A, Vonkeman HE (2021) Telemedicine for patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic; a positive experience in the Netherlands. Rheumatol Int 41(3):565–573
doi: 10.1007/s00296-020-04771-6 pubmed: 33449162 pmcid: 7809638
Tornero-Molina J, Sánchez-Alonso F, Fernández-Prada M, Bris-Ochaita ML, Sifuentes-Giraldo A, Vidal-Fuentes J (2020) Tele-rheumatology during the COVID-19 pandemic. Reumatol Clin 18(3):157–163
doi: 10.1016/j.reuma.2020.10.004 pubmed: 33214110 pmcid: 7598343
Howren A, Aviña-Zubieta JA, Rebić N, Dau H, Gastonguay L, Shojania K, Davidson E, De Vera MA (2020) Virtual rheumatology appointments during the COVID-19 pandemic: an international survey of perspectives of patients with rheumatic diseases. Clin Rheumatol 39(11):3191–3193
doi: 10.1007/s10067-020-05338-3 pubmed: 32803570 pmcid: 7429087
Thomason J, Bays A, Mantilla B, Huang I, Najjar R, Singh N, Wysham K, Hughes G (2022) Non-English language preference associated with decreased rheumatology telehealth use during the COVID-19 pandemic. ACR Open Rheumatol 4(5):385–394
doi: 10.1002/acr2.11407 pubmed: 35084116 pmcid: 9096515
Gossec L, Guyard F, Leroy D, Lafargue T, Seiler M, Jacquemin C, Molto A, Sellam J, Foltz V, Gandjbakhch F et al (2019) Detection of flares by decrease in physical activity, collected using wearable activity trackers in rheumatoid arthritis or axial spondyloarthritis: an application of machine learning analyses in rheumatology. Arthritis Care Res (Hoboken) 71(10):1336–1343
doi: 10.1002/acr.23768 pubmed: 30242992

Auteurs

Mithu Maheswaranathan (M)

Division of Rheumatology and Immunology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA. mithunan.maheswaranathan@duke.edu.

Bruce Miller (B)

Department of Medicine, University of California San Diego School of Medicine, La Jolla, San Diego, CA, USA.

Natasha Ung (N)

NSW Health, St Leonards, NSW, Australia.
University of Sydney, Camperdown, NSW, Australia.

Rashmi Sinha (R)

Systemic JIA Foundation, Cincinnati, OH, USA.

Carly Harrison (C)

LupusChat, New York, NY, USA.
COVID-19 Global Rheumatology Alliance, New York, NY, USA.

Bugra Han Egeli (BH)

Department of Pediatrics, Children's Hospital of Los Angeles, University of Southern California, Los Angeles, CA, USA.

Huseyin Berk Degirmenci (HB)

Section of Rheumatology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.

Emily Sirotich (E)

COVID-19 Global Rheumatology Alliance, New York, NY, USA.
Yale University School of Medicine, New Haven, CT, USA.

Jean W Liew (JW)

Section of Rheumatology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.

Rebecca Grainger (R)

Department of Medicine, University of Otago Wellington, Wellington, New Zealand.

Eugenia Y Chock (EY)

Section of Rheumatology, Department of Medicine, Yale School of Medicine, New Haven, CT, USA.

Classifications MeSH